- Home
- TCI vs RCKT Comparison
TCI vs RCKT Comparison
Compare TCI & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCI
- RCKT
- Stock Information
- Founded
- TCI 1983
- RCKT 1999
- Country
- TCI United States
- RCKT United States
- Employees
- TCI N/A
- RCKT N/A
- Industry
- TCI Real Estate
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- TCI Finance
- RCKT Health Care
- Exchange
- TCI Nasdaq
- RCKT Nasdaq
- Market Cap
- TCI 357.8M
- RCKT 328.6M
- IPO Year
- TCI N/A
- RCKT N/A
- Fundamental
- Price
- TCI $45.85
- RCKT $3.22
- Analyst Decision
- TCI
- RCKT Buy
- Analyst Count
- TCI 0
- RCKT 13
- Target Price
- TCI N/A
- RCKT $12.96
- AVG Volume (30 Days)
- TCI 1.4K
- RCKT 5.7M
- Earning Date
- TCI 11-06-2025
- RCKT 11-06-2025
- Dividend Yield
- TCI N/A
- RCKT N/A
- EPS Growth
- TCI 11.20
- RCKT N/A
- EPS
- TCI 0.76
- RCKT N/A
- Revenue
- TCI $47,730,000.00
- RCKT N/A
- Revenue This Year
- TCI N/A
- RCKT N/A
- Revenue Next Year
- TCI N/A
- RCKT $108.43
- P/E Ratio
- TCI $60.00
- RCKT N/A
- Revenue Growth
- TCI N/A
- RCKT N/A
- 52 Week Low
- TCI $25.50
- RCKT $2.19
- 52 Week High
- TCI $48.00
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- TCI 51.17
- RCKT 49.27
- Support Level
- TCI $45.43
- RCKT $3.12
- Resistance Level
- TCI $46.96
- RCKT $3.30
- Average True Range (ATR)
- TCI 0.51
- RCKT 0.18
- MACD
- TCI -0.26
- RCKT -0.02
- Stochastic Oscillator
- TCI 51.40
- RCKT 20.03
About TCI Transcontinental Realty Investors Inc.
Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.